Your support fuels our research to #EndALS! Donate Now

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS Research News

Tuesday, December 27, 2022
ALS TDI's 2022 Milestones
You Need Treatments. We Own the Problem. We Do the Research.
read more
Monday, December 12, 2022
What Clinical Trials are Recruiting Right Now?
A list of phase 3 clinical trials recruiting in the United States as of December 2022.
read more
Wednesday, November 30, 2022
What are Pharmacokinetic and Pharmacodynamic Studies?
For anyone who follows drug development closely, the terms pharmacodynamics (PD) and pharmacokinetic
read more
From trial readouts to news from our lab, you can find all of the latest ALS research news here.

ALS TDI Community Blog

Monday, January 23, 2023
Tri-State Trek Debuts New, Improved Format and Location in 2023
This year’s ride will feature more options for riders of all abilities while keeping the same #TrekFamily spirit.
read more
Tuesday, January 17, 2023
Your ALS Guide: A Hub for Answering Important Questions about Living with ALS
Your ALS Guide is a website offering a wealth of content about living with ALS, caregiving, adaptive technology, and more.
read more
Friday, December 23, 2022
Racing for ALS Celebrates a Big 2022, and Bigger Things to Come in 2023
Racing for ALS added more races and new services in 2022, raising record funds for ALS research. In 2023 they’re looking to do even more.
read more
Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Wednesday, September 28, 2022
ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala
Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research.
read more
Tuesday, March 1, 2022
Tegoprubart: AT-1501’s New Name
AT-1501, a drug invented at the ALS Therapy Development Institute (ALS TDI) and being developed by Eledon Pharmaceuticals, has a new name: tegoprubart.
read more
A complete list of press releases from the ALS Therapy Development Institute.
Follow Us
Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!
Media Contact
We'd love to share our story with you. Speak to our team about our unique approach to end ALS.